PosterSessionOnline
ESMO Breast Cancer 2023
ESMO Asia 2019 - Poster Display Session | European Society for Medical Oncology | Flickr
ESMO-2019-Poster-639P-Xavier-Matias-Guiu-MSI | Biocartis
SAKK presentations at the ESMO Congress 2021
NET COVID-19 Survey Results Presented at ESMO 2021 | COR2ED
Genialis ESMO 2022
ESMO 2020 - Hallmarks of Cancer - Agendia
Poster Presented at the ESMO Immuno-Oncology Congress - Immunophotonics
Anaveon announces poster presentation at the 2023 European Society for Medical Oncology Annual Meeting - anaveon
ESMO Asia 2019 - Poster Display Session | European Society for Medical Oncology | Flickr
PAK4 as a Potential Marker for Poor Response to Immunotherapy in Melanoma Patients - Biognosys
ESMO 2022 | Seagen Congress Presentations
Explicyte poster at ESMO IO Congress 2019 - by Explicyte Immuno-Oncology
ESMO Asia 2017 | Help Us Spread the Word
ESMO14 - Poster: STRIDE, a randomised, phase 2, open-label study of sipuleucel-T with concurrent versus sequential enzalutamide in metastatic castration-resistant prostate cancer (mCRPC)
ESMO Poster
ESMO Asia 2019 - Poster Display Session | European Society for Medical Oncology | Flickr
Presentato ad Esmo il poster sulla survey “Metastatic Breast Cancer: how and how often we communicate?”
PosterSessionOnline
INCA poster wins "Best Poster" at ESMO in Munich - NeuroEndocrine Cancer Australia
Poster presented at ESMO 2018 Congress: 430P - Phase I study: Safety and tolerability of Varlitinib (VAR) in combination with Oxaliplatin and Capecitabine (COX) or Oxaliplatin and 5-FU (FOL) in advanced solid
VBI Vaccines Announces Biomarker Data from VBI-1901 Phase 1/2a Study in Recurrent GBM Presented at ESMO Virtual Congress 2020 - VBI Vaccines
PosterSessionOnline
SAKK at the European Society for Medical Oncology (ESMO) Congress 2022
INCA presents poster at ESMO highlighting challenges in access to diagnosis and treatments for neuroendocrine cancer patients – UKI NETS
Poster Presented at the ESMO Immuno-Oncology Congress - Immunophotonics
ESMO-2019-Poster-1415P-Martin-Reijans-ctEGFR | Biocartis
